BAŞARAN, G. Et Al. 2008. Benefit from adjuvant anthracyclines according to hormone receptor status. 44th American Society of Clinical Oncology (ASCO) Annual Meeting .

BAŞARAN, G., ÇABUK, D., Teomete, M., GÜLLÜOĞLU, M. B., KAYA, H., DANE, F., ... YUMUK, P. F.(2008). Benefit from adjuvant anthracyclines according to hormone receptor status . 44th American Society of Clinical Oncology (ASCO) Annual Meeting

BAŞARAN, GÜL Et Al. "Benefit from adjuvant anthracyclines according to hormone receptor status," 44th American Society of Clinical Oncology (ASCO) Annual Meeting, 2008

BAŞARAN, GÜL Et Al. "Benefit from adjuvant anthracyclines according to hormone receptor status." 44th American Society of Clinical Oncology (ASCO) Annual Meeting , 2008

BAŞARAN, G. Et Al. (2008) . "Benefit from adjuvant anthracyclines according to hormone receptor status." 44th American Society of Clinical Oncology (ASCO) Annual Meeting .

@conferencepaper{conferencepaper, author={GÜL BAŞARAN Et Al. }, title={Benefit from adjuvant anthracyclines according to hormone receptor status}, congress name={44th American Society of Clinical Oncology (ASCO) Annual Meeting}, city={}, country={}, year={2008}}